Karyopharm Extends Forbearance Period to November 1, 2026
Karyopharm Therapeutics extended the forbearance period under its forbearance agreement to November 1, 2026.
Karyopharm Therapeutics extended the forbearance period under its forbearance agreement to November 1, 2026.